Pörssitiedote26.05.2024 klo 10.15Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Pörssitiedote30.04.2024 klo 11.05Cline Scientific provides an update on the company's financial position
Lehdistötiedote15.03.2024 klo 09.45BioStock: Scientific Advisor on the potential of Cline's cell therapy for cartilage damage
Lehdistötiedote01.03.2024 klo 09.30Cline: StemCART updates on achieved milestones on the way to phase 1 study
Pörssitiedote23.02.2024 klo 09.30Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Lehdistötiedote13.02.2024 klo 09.30Cline Scientific advisor discusses the future of cartilage damage treatment
Pörssitiedote18.01.2024 klo 21.12Cline Scientific provides an update on the company's financial position
Lehdistötiedote18.01.2024 klo 20.15Cline Scientific provides an update on the company's financial position
Lehdistötiedote22.12.2023 klo 13.13Cline: Medtech4Health supports capacity building in the strategy and regulatory pathway for StemCART
Lehdistötiedote08.12.2023 klo 13.00CORRECTION: Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Lehdistötiedote07.12.2023 klo 14.03Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future
Lehdistötiedote21.11.2023 klo 12.18Judgment in the market manipulation case against Cline Scientific's CEO Patrik Sundh
Lehdistötiedote30.10.2023 klo 10.38BioStock: Cline aims for stem cell breakthrough with nanotechnology